Benefits and harms of oral anticoagulant therapy in chronic kidney disease: a systematic review and meta-analysis
Background: Effects of oral anticoagulation in chronic kidney disease (CKD) are uncertain. Purpose: To evaluate the benefits and harms of vitamin K antagonists (VKAs) and non–vitamin K oral anticoagulants (NOACs) in adults with CKD stages 3 to 5, including those with dialysis-dependent end-stage ki...
| Main Author: | |
|---|---|
| Format: | Journal article |
| Published: |
American College of Physicians
2019
|